PHENOTYPIC SUSCEPTIBILITY TO VRCO7-523LS AND ITS CORRELATES IN THE ACTG A5357 STUDY.

MLA

Taiwo, Babafemi, et al. “Phenotypic Susceptibility to Vrco7-523Ls and Its Correlates in the Actg A5357 Study.” Topics in Antiviral Medicine, vol. 31, no. 2, Apr. 2023, pp. 229–30. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=163303828&authtype=sso&custid=ns315887.

APA

Taiwo, B., Reeves, J., Zheng, Y. (Evelyn), Lie, Y., Burke, L., Garma, L., Petropoulos, C. J., Belaunzaran-Zamudio, P. F., Koup, R. A., Rathod, P., Tiu, J., Baer, J., Kiser, J., Dorosh, M., Bar, K., & Tebas, P. (2023). Phenotypic Susceptibility to Vrco7-523Ls and Its Correlates in the Actg A5357 Study. Topics in Antiviral Medicine, 31(2), 229–230.

Chicago

Taiwo, Babafemi, Jackie Reeves, Yu (Evelyn) Zheng, Yolanda Lie, Leah Burke, Lucio Garma, Christos J. Petropoulos, et al. 2023. “Phenotypic Susceptibility to Vrco7-523Ls and Its Correlates in the Actg A5357 Study.” Topics in Antiviral Medicine 31 (2): 229–30. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=163303828&authtype=sso&custid=ns315887.